Nordihydroguaiaretic acid (NDGA) inhibits ritonavir-induced endothelial dysfunction in porcine pulmonary arteries
Author(s) -
Jian-Ming Lü,
Jacobo Nurko,
Jun Jiang,
Sarah M. Weakley,
Peter H. Lin,
Qizhi Yao,
Changyi Chen
Publication year - 2011
Publication title -
medical science monitor
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.636
H-Index - 85
eISSN - 1643-3750
pISSN - 1234-1010
DOI - 10.12659/msm.882040
Subject(s) - nordihydroguaiaretic acid , enos , pharmacology , endothelial dysfunction , ritonavir , medicine , endothelium , oxidative stress , chemistry , nitric oxide , glutathione , nitric oxide synthase , biochemistry , immunology , enzyme , lipoxygenase , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy
HIV infection and treatment with highly active antiretroviral therapy (HAART) including HIV protease inhibitor ritonavir (RTV) have been associated with endothelial dysfunction and cardiovascular disease including pulmonary arterial hypertension. The objective of this study was to determine if nordihydroguaiaretic acid (NDGA), a natural herbal antioxidant found in the creosote bush Larrea tridentate, can protect vascular tissues against RTV-induced vascular injury.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom